Prof. Jiang Hua (姜桦) — Cervical Cancer, Sandwich Therapy & Fertility-Sparing Surgery | Red House Hospital Shanghai
For international patients with cervical cancer — whether newly diagnosed, locally advanced, or facing the difficult question of whether fertility can be preserved — Prof. Jiang Hua (姜桦) at the Obstetrics & Gynecology Hospital of Fudan University (known as “Red House Hospital,” 红房子医院) offers a combination of clinical innovation, institutional leadership, and outcomes data that is difficult to match anywhere in the world.
As Director of one of China's most storied women's health institutions — a hospital with over a century of history and a national reputation for gynecologic excellence — Prof. Jiang brings 30 years of focused gynecologic oncology expertise to her patients. Her clinical innovations in advanced cervical cancer treatment and fertility-sparing surgery have produced outcomes that are recognized as internationally leading.
Specialty Focus
- Cervical cancer: modified surgical techniques, sandwich therapy for advanced disease, fertility-sparing options
- Advanced cervical cancer: neoadjuvant chemotherapy + modified radical surgery + adjuvant therapy (“sandwich therapy”)
- Fertility-sparing cervical cancer surgery: radical trachelectomy with internationally leading pregnancy outcomes
- Ovarian cancer: surgical management and comprehensive treatment
- Endometrial cancer: surgical staging and fertility-sparing approaches
- Gynecologic cancer multidisciplinary treatment
Academic & Clinical Titles
- Chief Physician & Professor, Director, Obstetrics & Gynecology Hospital of Fudan University (Red House Hospital, 红房子医院)
- 30 years of clinical expertise in gynecologic oncology
- Developer of the modified surgical technique and “sandwich therapy” for advanced cervical cancer
- Fertility-sparing surgery program with internationally leading pregnancy and delivery outcomes
Sandwich Therapy for Advanced Cervical Cancer: 85% Three-Year Disease-Free Survival
Locally advanced cervical cancer (Stages IB3–IVA) presents one of the most challenging treatment decisions in gynecologic oncology. The standard approach — concurrent chemoradiation with brachytherapy — is effective but carries significant long-term morbidity, particularly in younger patients, and may not be optimal for all presentations. Prof. Jiang Hua has developed and refined a modified surgical approach combined with “sandwich therapy” — a treatment sequence that integrates neoadjuvant chemotherapy, modified radical surgery, and adjuvant therapy in a structured protocol designed to maximize both oncological control and quality of life.
The results speak for themselves: Prof. Jiang's sandwich therapy approach achieves a three-year disease-free survival rate of 85% in advanced cervical cancer patients — an outcome that compares favorably with international benchmarks for this challenging patient population.
How sandwich therapy works:
- First layer (neoadjuvant chemotherapy): Platinum-based chemotherapy is administered before surgery to reduce tumor volume, improve resectability, and treat potential micrometastatic disease. Response to neoadjuvant chemotherapy also provides important prognostic information about tumor biology.
- Middle layer (modified radical surgery): Prof. Jiang's modified surgical technique is designed to achieve complete tumor removal while minimizing damage to adjacent structures — reducing the risk of urological, bowel, and sexual function complications that can significantly affect quality of life after standard radical hysterectomy.
- Final layer (adjuvant therapy): Postoperative radiation and/or chemotherapy based on pathological risk factors identified at surgery, ensuring comprehensive treatment of any residual microscopic disease.
This integrated approach reflects Prof. Jiang's philosophy that optimal cervical cancer treatment is not a single modality but a carefully sequenced combination — and that the sequence and technique matter as much as the individual components.
Fertility-Sparing Surgery: 50% Pregnancy Rate, 80% Full-Term Delivery Rate
For young women with early-stage cervical cancer who wish to preserve their fertility, the question is not only whether surgery can remove the cancer safely, but whether the reproductive outcomes after surgery are genuinely meaningful. Prof. Jiang Hua's fertility-sparing surgery program answers this question with data that is recognized as internationally leading:
- Pregnancy rate: 50% among patients who attempt conception after fertility-sparing surgery
- Full-term delivery rate: 80% among patients who achieve pregnancy
These outcomes reflect not only the technical quality of Prof. Jiang's surgical approach — which preserves uterine blood supply, cervical competence, and reproductive anatomy — but also the comprehensive perioperative and postoperative support her program provides, including cervical cerclage placement, obstetric monitoring protocols, and coordination with reproductive medicine specialists for patients who require assisted conception.
For international patients who have been told that fertility preservation is not possible, or who have received fertility-sparing surgery elsewhere with suboptimal reproductive outcomes, Prof. Jiang's program offers a genuine alternative grounded in the largest available evidence base from a single high-volume center.
Red House Hospital: A Century of Women's Health Excellence
The Obstetrics & Gynecology Hospital of Fudan University — affectionately known as “Red House Hospital” for its distinctive red-brick building — is one of China's most historic and respected women's health institutions. Founded over a century ago, it has been at the forefront of Chinese obstetrics and gynecology throughout its history, and today operates as a specialized hospital dedicated exclusively to women's health, with comprehensive capabilities in gynecologic oncology, reproductive medicine, maternal-fetal medicine, and general gynecology.
As Director of this institution, Prof. Jiang Jiang leads not only her own clinical program but the overall strategic direction of one of China's premier women's health centers. For international patients, the hospital's exclusive focus on women's health means that every aspect of the institutional infrastructure — from nursing care to anesthesia to pathology — is optimized for gynecologic patients.
Thirty Years of Gynecologic Oncology Expertise
Prof. Jiang's 30 years of focused gynecologic oncology practice have given her a depth of clinical experience that encompasses the full evolution of the field — from the era before laparoscopic surgery to the current age of immunotherapy and molecular targeted agents. She has managed patients with every presentation and stage of cervical, ovarian, and endometrial cancer, and has developed the clinical judgment that comes only from sustained high-volume practice in a demanding subspecialty.
For patients with complex or unusual presentations — recurrent disease after prior treatment, tumors with unusual histology, or cases where prior fertility-sparing surgery has been unsuccessful — Prof. Jiang's depth of experience is particularly valuable.
Who Should Consider Consulting Prof. Jiang Hua
- Young women with early-stage cervical cancer who wish to preserve fertility and want the best possible reproductive outcomes after surgery
- Patients with locally advanced cervical cancer (Stages IB3–IVA) seeking an alternative to standard chemoradiation
- Patients who have received prior fertility-sparing surgery with suboptimal outcomes and want a second opinion
- Patients with recurrent cervical cancer seeking salvage treatment options
- Patients with ovarian or endometrial cancer seeking expert gynecologic oncology evaluation
- Patients seeking a second opinion from a senior gynecologic oncology authority with 30 years of experience
How CMCS Connects You with Prof. Jiang Hua
China Medical Concierge Shanghai (CMCS) facilitates access to Prof. Jiang Hua for international patients with cervical cancer and other gynecologic malignancies. Our team manages the full coordination process — from remote case review and medical record translation to appointment scheduling, interpretation, and in-hospital support.
To begin, patients or their families are encouraged to share available medical records including pathology reports (with histological type, grade, and any molecular testing), MRI pelvis, CT chest/abdomen/pelvis, PET-CT if available, tumor markers (SCC, CEA, CA-125 as appropriate), and prior treatment summaries. Prof. Jiang's team can conduct an initial remote assessment before any travel to Shanghai is required.
CMCS provides end-to-end support including:
- Medical record translation (English, Arabic, French, and other languages)
- Remote pre-consultation case review
- Appointment coordination with Prof. Jiang Hua at Red House Hospital Shanghai
- On-site interpretation during consultations and procedures
- Reproductive medicine coordination for fertility-sparing surgery patients
- Post-consultation summary and follow-up support
Contact CMCS to Connect with Prof. Jiang Hua
📧 contract@medicalsh.com
💬 WhatsApp: https://wa.me/message/3AM6KAGCW2BAD1
🌐 www.medicalsh.com
CMCS – China Medical Concierge Shanghai connects international patients with Shanghai's leading specialists. We are a health management company, not a hospital. All clinical decisions are made by the treating physician.
0 comentarios